Subtotal Pleurectomy with Intrathoracic Chemo Hyperthermia (HITHOC) for IVa Thymomas: De Novo Versus Recurrent Pleural Disease.
HITHOC
IVa Masaoka
intrathoracic chemotherapy
pleural involvement
subtotal pleurectomy
thymic surgery
thymomas
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
14 Oct 2022
14 Oct 2022
Historique:
received:
24
08
2022
revised:
03
10
2022
accepted:
11
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
Stage IVa thymoma is a rare disease without a standard of care. Subtotal pleurectomy and HITHOC introduced in highly selected patients may provide interesting oncologic results. The purpose of this study was to distinguish de novo stage IVa tumors (DNT) from distant relapse (DR) with respect to post-operative and long-term outcomes to provide the procedure efficacy. From July 1997-December 2021, 40 patients with IVa pleural involvement were retrospectively analyzed. The surgical procedure was subtotal pleurectomy and HITHOC (cisplatin 50 mg/m Mean age was 52 ± 12 years. B2 and B3 thymomas were preponderant (27; 67.5%). The median number of pleural nodes were nine (4-81) vs. five (1-36); Subtotal pleurectomy with HITHOC in IVa offers satisfying results in highly selected patients, for both DNT and DR. Due to the disease rarity, multicentric studies are needed to define HITHOC as a standard of care.
Identifiants
pubmed: 36291819
pii: cancers14205035
doi: 10.3390/cancers14205035
pmc: PMC9599523
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Thorac Oncol. 2018 Nov;13(11):1762-1770
pubmed: 30138763
Ann Transl Med. 2021 Jun;9(11):953
pubmed: 34350268
Ann Thorac Surg. 2006 Oct;82(4):1234-9
pubmed: 16996913
J Surg Oncol. 2013 Jun;107(7):735-40
pubmed: 23386426
Lung Cancer. 2017 Jun;108:1-6
pubmed: 28625619
PLoS One. 2019 Mar 21;14(3):e0197655
pubmed: 30897085
J Thorac Oncol. 2017 Oct;12(10):1571-1581
pubmed: 28694035
Ann Thorac Surg. 2009 Sep;88(3):952-7
pubmed: 19699926
Langenbecks Arch Chir. 1988;373(3):189-96
pubmed: 3288830
Rev Prat. 2017 Apr;67(4):430-434
pubmed: 30512890
Cancer Chemother Pharmacol. 1995;36(5):404-10
pubmed: 7634382
N Engl J Med. 2018 Jan 18;378(3):230-240
pubmed: 29342393
J Thorac Oncol. 2014 Jul;9(7):1018-1022
pubmed: 24926546
Gynecol Oncol. 2005 Feb;96(2):301-6
pubmed: 15661212
Ann Surg Oncol. 2015 May;22(5):1708-15
pubmed: 25201499
J Thorac Oncol. 2021 Dec;16(12):2144-2149
pubmed: 34455064
Curr Opin Oncol. 2017 Mar;29(2):112-117
pubmed: 28027106
Eur J Cardiothorac Surg. 2011 May;39(5):e133-8
pubmed: 21420311
Interact Cardiovasc Thorac Surg. 2020 May 1;30(5):765-772
pubmed: 32170942
Eur J Cardiothorac Surg. 2015 Mar;47(3):563-6
pubmed: 24872472
J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S260-5
pubmed: 20859116
Crit Rev Oncol Hematol. 2016 Mar;99:332-50
pubmed: 26818050
Anticancer Drugs. 2005 Oct;16(9):1009-16
pubmed: 16162978
Eur J Cardiothorac Surg. 2014 Sep;46(3):361-8
pubmed: 24482389
Anticancer Drugs. 2003 Jan;14(1):57-65
pubmed: 12544259
Ann Transl Med. 2021 Jun;9(11):957
pubmed: 34350272
Ann Thorac Surg. 2019 Feb;107(2):e157-e160
pubmed: 30253161